Trade Summary

6 days ago, Prange Karen, serving as Dir at AtriCure, Inc. (ATRC), sold 3,564 shares at $38.80 per share, for a total transaction value of $138,283.20. Following this transaction, Prange Karen now holds 22,809 shares of ATRC.

This sale represents a 13.51% decrease in Prange Karen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 9:18 AM ET, 2 days after the trade was made.

AtriCure, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.